Predictions
Medigene AG
Start price
Target price
Perf. (%)
€1.87
24.06.23
24.06.23
€1.00
24.06.24
24.06.24
-35.66%
08:20
08:20
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
VERBIO Vereinigte BioEnergie AG
Start price
Target price
Perf. (%)
€42.86
16.06.23
16.06.23
€47.00
16.06.24
16.06.24
-49.98%
08:00
08:00
Could be worthwhile Investment >10% per year
Sfc Energy AG
Start price
Target price
Perf. (%)
€25.30
15.06.23
15.06.23
€26.00
15.06.24
15.06.24
-2.57%
08:06
08:06
Top Rating
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
GFT Technologies AG
Start price
Target price
Perf. (%)
€28.62
14.06.23
14.06.23
€32.00
14.06.24
14.06.24
-2.87%
20.05.24
20.05.24
Risky Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Low dividend yield expected
SNP Schneider-Neureither & Partner AG
Start price
Target price
Perf. (%)
€33.70
31.05.23
31.05.23
-
31.05.24
31.05.24
35.91%
20.05.24
20.05.24
Heliad Equity Partners KGaA
Start price
Target price
Perf. (%)
€4.84
31.05.23
31.05.23
-
31.05.24
31.05.24
-6.61%
20.11.23
20.11.23
2G Energy AG
Start price
Target price
Perf. (%)
€24.40
30.08.22
30.08.22
-
28.12.25
28.12.25
6.72%
08:00
08:00
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
High Investments for future growth
Süss MicroTec SE
Start price
Target price
Perf. (%)
€13.94
16.06.22
16.06.22
€45.00
22.04.26
22.04.26
298.85%
08:01
08:01
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Rising EBIT margin expected
Elmos Semiconductor AG
Start price
Target price
Perf. (%)
€43.25
16.06.22
16.06.22
€54.00
22.04.26
22.04.26
84.51%
08:01
08:01
Eckert & Ziegler Strahlen- und Medizintechnik AG
Start price
Target price
Perf. (%)
€48.92
25.04.22
25.04.22
€120.00
03.02.25
03.02.25
-4.01%
08:14
08:14
Higher EBIT margin than peer group
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High valuation